We're pleased to share our annual report, which spans the past two years of exciting activities and fascinating stories of our department.
Duke Pathology Annual Report 2021-2022 Graphic
Read our Annual Report 2021-2022

In addition to the main feature story celebrating the Biorepository & Precision Pathology Center’s (BRPC) 10th anniversary, our department has also partnered with Duke Cancer Institute (DCI) on four articles connected to the BRPC feature that take a deep dive into our joint clinical and research collaborations and future directions. This is especially timely as DCI celebrates 50 years as a National Cancer Institute-designated Comprehensive Cancer Center and recognizes the important role that Duke Pathology has played and continues to play in its milestone achievements. These articles are linked to from the print and digital versions of the annual report, and we've also included them here for easy access. 

This page also includes a collection of the complete features about our long-term staff that were shortened slightly for the print and digital versions of the report.

Cancer precision medicine image

Data at Their Digital Fingertips: Tissue-based Research and Precision Cancer Medicine Comes of Age

In 2012, Duke Cancer Institute and the Duke University School of Medicine committed to a five-year, three-million-dollar investment in a new Duke BioRepository & Precision Pathology Center (BRPC) — a clinical research and discovery resource with its administrative home in the Department of Pathology. Spurred by key investments in technology, services, and personnel, the BRPC grew, thrived, and progressively built a national reputation. Under the leadership of Shannon McCall, MD: the BRPC joined a national molecular registry of tumors and became the base for the NCI-supported Southern Division of the Cooperative Human Tissue Network; the Precision Cancer Medicine Initiative was developed and expanded; and multiple large-scale research projects were funded.
Collage of DCI and BRPC faculty and staff

Partners to the Core

The success of the BRPC over the past decade represents the evolution and extension of the Department of Pathology’s support and commitment to cancer research. Learn about some notable BRPC/DCI cancer research collaborations and why the partnership is core to winning big grants for cancer research.
Debra Andersen

Long-Term Staff Recognition: Debra Anderson

Debra “Debbie” Andersen, formerly Debbie Harris, retired from her role as GME Program Coordinator in April 2022 after nearly 48 years of service at Duke, 31 of them in Pathology.
Claudia Jones, MD

Long-Term Staff Recognition: Claudia Jones, MD

Dr. Jones, who retired from our department on Nov. 30, 2021, had a highly successful, 22-year career with Duke Pathology. In honor of her many contributions to our department, medical center, and university, she was named Associate Professor of Pathology Emeritus on Dec. 1, 2021.

Susan Reeves

Long-Term Staff Recognition: Susan Reeves

On Sept. 10, 2021, Susan Reeves, a constant presence and guiding force in the Department of Pathology’s PhotoPath group for four decades, retired.